Neurotransmitters: emerging targets in cancer

SH Jiang, LP Hu, X Wang, J Li, ZG Zhang - Oncogene, 2020 - nature.com
Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the
stimulatory or inhibitory neuronal functions through binding to their respective receptors. In …

Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations

IC Hvinden, T Cadoux-Hudson, CJ Schofield… - Cell Reports …, 2021 - cell.com
The most frequently mutated metabolic genes in human cancer are those encoding the
enzymes isocitrate dehydrogenase 1 (IDH1) and IDH2; these mutations have so far been …

Integrating Multi-Omics analysis for enhanced diagnosis and treatment of glioblastoma: A comprehensive Data-Driven approach

A Barzegar Behrooz, H Latifi-Navid, SC da Silva Rosa… - Cancers, 2023 - mdpi.com
Simple Summary The most prevalent and lethal primary brain tumor, glioblastoma
multiforme (GBM), exhibits fast growth and widespread invasion and has a poor prognosis …

Understanding the molecular mechanisms of succinic semialdehyde dehydrogenase deficiency (SSADHD): towards the development of SSADH-targeted medicine

HHC Lee, GE McGinty, PL Pearl… - International journal of …, 2022 - mdpi.com
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare genetic disorder
caused by inefficient metabolic breakdown of the major inhibitory neurotransmitter, γ …

Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis

ML Dahn, HR Walsh, CA Dean, MA Giacomantonio… - Metabolomics, 2022 - Springer
Abstract Introduction Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell (CSC)
marker and in breast cancer it is associated with triple-negative/basal-like subtypes and …

Extensive astrocyte metabolism of γ‐aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex

JV Andersen, E Jakobsen, EW Westi, MEK Lie… - Glia, 2020 - Wiley Online Library
Synaptic transmission is closely linked to brain energy and neurotransmitter metabolism.
However, the extent of brain metabolism of the inhibitory neurotransmitter γ‐aminobutyric …

Ligand-gated ion channels as targets for treatment and management of cancers

R Rao, S Shah, D Bhattacharya, DK Toukam… - Frontiers in …, 2022 - frontiersin.org
Ligand-gated ion channels are an ionotropic receptor subtype characterized by the binding
of an extracellular ligand, followed by the transient passage of ions through a …

Neurotransmitters: potential targets in Glioblastoma

Q Huang, L Chen, J Liang, Q Huang, H Sun - Cancers, 2022 - mdpi.com
Simple Summary Aiming to discover potential treatments for GBM, this review connects
emerging research on the roles of neurotransmitters in the normal neural and the GBM …

Shedding light on the role of neurotransmitters in the microenvironment of pancreatic cancer

Y Liang, H Li, Y Gan, H Tu - Frontiers in cell and developmental …, 2021 - frontiersin.org
Pancreatic cancer (PC) is a highly lethal malignancy with a 5-year survival rate of less than
8%. The fate of PC is determined not only by the malignant behavior of the cancer cells, but …

Regulative roles of metabolic plasticity caused by mitochondrial oxidative phosphorylation and glycolysis on the initiation and progression of tumorigenesis

N Niu, J Ye, Z Hu, J Zhang, Y Wang - International Journal of Molecular …, 2023 - mdpi.com
One important feature of tumour development is the regulatory role of metabolic plasticity in
maintaining the balance of mitochondrial oxidative phosphorylation and glycolysis in cancer …